Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 30 Issue 4
. 
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2012  >  30(4): 299-301

ZHOU Xin, LI Hong-jie, LIU Rui-ning. Analysis of typical cases in practice of prescription comment[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 304-307.
Citation: ZHANG Su-jiang, LIN Lu. The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(4): 299-301.
shu

The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease

  • 1st People′s Hospital of Taizhou, Taizhou 318020, China

  • Received Date: 2012-04-21
  • Rev Recd Date: 2012-05-29
  • Objective To explore the effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease (NAFLD),Methods A total of 148 patients suffered hypertension and NAFLD were included in the study. Patients were divided into the observed group the compared group.which were given valsartan and analodipine respectively. The difference of the blood pressure,liver ultrasound,liver function,serum lipids,insulin resistance index (RI) and clinical curative effect were compared between the two groups. Results The curative effect in the observed group (93.24%) was significantly higher than that in the compared group (81.08%);After treatment,the alanine aminolransferase,cholesterol,triglyceride,low density lipoprotein and RI in the observed group were significantly lower than that in the compared group (P<0.05). Conclusion The valsartan had a good effect on patients suffered hypertension and NAFLD.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0401234Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 85.7 %FULLTEXT: 85.7 %META: 12.0 %META: 12.0 %PDF: 2.3 %PDF: 2.3 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 23.6 %其他: 23.6 %上海: 0.4 %上海: 0.4 %北京: 14.0 %北京: 14.0 %南平: 1.2 %南平: 1.2 %安阳: 0.4 %安阳: 0.4 %张家口: 0.4 %张家口: 0.4 %普洱: 0.4 %普洱: 0.4 %杭州: 0.8 %杭州: 0.8 %武汉: 0.4 %武汉: 0.4 %澳门: 0.4 %澳门: 0.4 %福州: 0.4 %福州: 0.4 %芒廷维尤: 22.5 %芒廷维尤: 22.5 %西宁: 34.9 %西宁: 34.9 %龙岩: 0.4 %龙岩: 0.4 %其他上海北京南平安阳张家口普洱杭州武汉澳门福州芒廷维尤西宁龙岩Highcharts.com
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3176) PDF downloads(601) Cited by()

Related
Proportional views

The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease

  • 1st People′s Hospital of Taizhou, Taizhou 318020, China
  • Received Date: 2012-04-21
  • Rev Recd Date: 2012-05-29

Abstract: Objective To explore the effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease (NAFLD),Methods A total of 148 patients suffered hypertension and NAFLD were included in the study. Patients were divided into the observed group the compared group.which were given valsartan and analodipine respectively. The difference of the blood pressure,liver ultrasound,liver function,serum lipids,insulin resistance index (RI) and clinical curative effect were compared between the two groups. Results The curative effect in the observed group (93.24%) was significantly higher than that in the compared group (81.08%);After treatment,the alanine aminolransferase,cholesterol,triglyceride,low density lipoprotein and RI in the observed group were significantly lower than that in the compared group (P<0.05). Conclusion The valsartan had a good effect on patients suffered hypertension and NAFLD.

ZHOU Xin, LI Hong-jie, LIU Rui-ning. Analysis of typical cases in practice of prescription comment[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 304-307.
Citation: ZHANG Su-jiang, LIN Lu. The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(4): 299-301.
shu

    HTML

Catalog

  • HTML

版权所有：《药学实践与服务》编辑委员会

Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

网站备案号 沪ICP备05003363号-1

Supported by: Beijing Renhe Information Technology Co., Ltd.  

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return